Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas
-
Upload
independent -
Category
Documents
-
view
2 -
download
0
Transcript of Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas
Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas
Introduction
The obstruction of blood flow or ischemia is relativelyfrequent in numerous clinical interventions and physio-
pathological processes. Although the recovery of bloodflow is normally followed by the restoration of tissuefunction, the reperfusion process may induce a significant
cell damage [1, 2]. The generation of highly reactive oxygenspecies mostly determine tissue injury during ischemia/reperfusion (IR) syndrome [3, 4]. In particular, the pancreas
is subjected to IR injury during tissue transplantation andother pathological situations characterized by a reductionof abdominal blood flow such as post-traumatic hemor-
rhage, septic syndromes, cardiopathies, vascular dysfunc-tion, embolic-thrombosis processes, and all surgicalinterventions in which a regional arterial bypass or vascularclamping is required.
Different experimental studies have shown that the induc-tion of oxidative stress is the underlying mechanism of IRinjury in pancreas [5–7]. Sanfey et al. [8] showed that the
treatment with enzymatic antioxidants [superoxide dismu-tase (SOD) and catalase (CAT)] reduces the histological signsof tissue damage (glandular edema) induced by IR in
pancreas. The regulation of the extracellular concentration
of nitric oxide [9] or free radicals [10] also reduces pancreatitisrelated to IR. In addition, other experimental studies haverelated the impairment of microcirculation with the severity
of acute pancreatitis induced by IR and toxin [11–15].Fujimoto et al. [16] showed that the induction of pancreatitisby IR is accompanied by the presence of apoptoticmarkers in
the acini.Melatonin (N-acetyl-5-methoxytryptamine), a lipophilic
indole amine derived from tryptophan. Melatonin is apotent antioxidant, well tolerate and without toxicity upon
its administration. Melatonin has a powerful capacity toscavenge free radicals and prevents tissue damage [17–19].In particular, melatonin prevents oxidative stress induced
by I/R in liver [20–22], brain [23, 24], myocardium [25],intestine [26, 27] and kidney [28]. Although, differentstudies described above have attempted to control oxidative
stress during IR-induced pancreatitis [8–10], we could notfind a study describing the cytoprotective effect of melato-nin against oxidative stress, cell death and tissue dysfunc-
tion in pancreas induced by IR.The aim of the study was to evaluate the cytoprotective
properties after the preventive or therapeutic administra-tion of melatonin against cell injury and dysfunction
induced by IR in pancreas.
Abstract: The pancreas is highly susceptible to the oxidative stress induced
by ischemia/reperfusion (IR) injury leading to the generation of acute
pancreatitis. Melatonin has been shown to be useful in the prevention of the
damage by ischemia-reperfusion in liver, brain, myocardium, gut and kidney.
The aim of the study was to evaluate the cytoprotective properties of
melatonin against injury induced by IR in pancreas. The obstruction of
gastro-duodenal and inferior splenic arteries induced pancreatic IR in male
Wistar rats. Melatonin was intraperitoneally administered before or/and
after IR injury. The animals were killed at 24 and 48 hr after reperfusion and
there were evaluated parameters of oxidative stress (lipoperoxides,
superoxide dismutase, catalase, glutathione peroxidase and reduced
glutathione), glandular endocrine and exocrine function (lipase, amylase,
insulin) and cell injury (apoptosis and necrosis). The IR induced a marked
enhancement of oxidative stress and impaired pancreatic function. The
histological analysis showed that IR induced acute pancreatitis with the
accumulation of inflammatory infiltrate, disruption of tissue structure, cell
necrosis and hemorrhage. Melatonin administration before or after
pancreatic IR prevented all tissue markers of oxidative stress, biochemical
and histological signs of apoptosis and necrosis, and restored glandular
function. No histological signs of pancreatitis were observed 48 hr after
reperfusion in 80% of the animals treated with melatonin, with only a mild
edematous pancreatitis being observed in the remaining rats. Preventive or
therapeutic administration of melatonin protected against the induction of
oxidative stress and tissue injury, and restored cell function in experimental
pancreatic IR in rats.
Francisco C. Munoz-Casares1,Francisco J. Padillo1, JavierBriceno1, Juan A. Collado2,Juan R. Munoz-Castaneda2,Rosa Ortega3, Adolfo Cruz1,Isaac Tunez4, Pedro Montilla4,Carlos Pera1 and Jordi Muntane2
1Department of General Surgery, 2Research
Unit and 3Department of Pathology, Reina
Sofia University Hospital; 4Department of
Biochemistry and Molecular Biology, School of
Medicine, Cordoba, Spain
Key words: cell death, ischemia-reperfusion,
melatonin, oxidative stress, pancreas
Address reprint requests to Francisco J.
Padillo, Departamento de Cirugıa, Hospital
Universitario Reina Sofıa, Avda. Menendez
Pidal s/n 14004 Cordoba, Espana.
E-mail: [email protected]
Received August 25, 2005;
accepted September 28, 2005.
J. Pineal Res. 2006; 40:195–203Doi:10.1111/j.1600-079X.2005.00291.x
� 2006 The AuthorsJournal compilation � 2006 Blackwell Munksgaard
Journal of Pineal Research
195
Methods
Animals
Male Wistar rat (200–350 g) received laboratory food
(Ebro Agrıcolas S.A., Sevilla, Spain) and water ad libitum.The animal room was controlled at constant temperature(22 ± 2�C), humidity and light cycle (08:00–20:00 hr).
Animal care and experimental protocols were in accordancewith the Guide for the care and use of laboratory animalsprepared by the National Academy of Sciences and
published by the National Institute of Health (NIHpublication no. 80-83, revised 1985).
Experimental procedures
Animals (n ¼ 65) were distributed in seven experimentalgroups: (i) control, (ii) sham operated (SO), (iii) sham
operated plus melatonin (SO-MEL), (iv) ischemia/reper-fusion (IR), (v) melatonin administration before IR (MEL-IR), (vi) melatonin administration after IR (IR-MEL), and
(vii) Melatonin administration before and after IR (MEL-IR-MEL). Control animals were not subjected to anysurgical intervention. SO animals were submitted to lapar-
otomy but without blood flow obstruction. IR animals weresubjected to obstruction of gastro-duodenal and inferiorsplenic arteries for 1 hr and subsequent reperfusion.MEL-IR rats received melatonin 30 min before arterial
obstruction. IR-MEL animals received melatonin duringreperfusion. MEL-IR-MEL animals received melatoninboth before and after arterial obstruction. All groups
excluding control animals were killed at 24 hr (five animals)and 48 hr (five animals). There were no differences betweencontrol, SO and SO-MEL groups in relation to all
parameters studied. Thus, only the data from the SO ratsare provided herein.All surgical procedure were carried with the animals
placed on a thermoregulated surface (Harvard Apparatus�
Ltd., Edenbridge, Kent, UK) specially designed for thepurpose and coupled to cold light sources (EuromexIlluminator EK-1; Euromex Microscopes Ltd., Aruhem,
the Netherlands). The animals were anesthetized with asolution including ketamine (Ketolar� 50 mg/mL, 80–85 mg/kg), diazepam (Valium� 10 mg/2 mL, 3–4 mg/kg)
and atropine (Atropina� 1 mg/mL, 0.05–0.06 mg/kg). IRwas carried out by the obstruction of gastro-duodenal andinferior splenic arteries for 1 hr using vascular clamps. The
obstruction induces a marked ischemia in two-thirds of thepancreas while one-third of the pancreas perfused by thesuperior splenic arteries continued to receive blood. Thereperfusion of the pancreas was initiated when the vascular
clamps were removed. After surgical intervention, theabdominal wall was sutured using absorbable material(Polyglactin 910, Vicryl� Ethicon, Johnson and Johnson,
Norderstedt, Germany) and the external skin with nonab-sorbable material (Seda, Mersilk�, Ethicon, Johnson andJohnson). Melatonin (Melatonin; Sigma Co, St Louis, MO,
USA) was administered intraperitoneally at a dose of10 mg/kg using 10% ethanol solution (8 mg/mL). Animalswere killed under anesthesia at 24 or 48 hr after experi-mental intervention removing blood samples and pancreas.
The pancreas was used for histological analysis, and for the
measurement of antioxidant status, lipoperoxides andapoptotic markers. The blood-derived serum was frozenand further used for the measurement of glucose, insulin,
amylase and lipase.
Measurement of lipid peroxidation and antioxidantstatus
The presence of lipid peroxides (malondialdehyde +4-hydroxynonenal) in tissue was determined using a com-
mercial assay (LPO-586; Byoxitech, OXIS International,Portland, OR, USA). The pancreas was homogenized in20 mm Tris-HCl pH 7.4 and centrifuged at 10,000 g during
15 min at 4�C. The assay is based on the reaction of achromogenic reagent, N-methyl-2phenylindole, with lipop-eroxides at 45�C. The results were expressed in relation tothe protein content.
The measurement of reduced glutathione (GSH) wasdetermined using a commercial assay GSH-400 (ByoxitechS.A). Briefly, all mercaptans present in the sample react
with 4-chloro-1-methyl-7-trifluromethyl-quinolinium meth-ylsulfate in a first chemical reaction. The second stepconsisted of the b-elimination reaction under alkaline
conditions of the product from the first reaction into achromogenic thione-derived product.Glutathione peroxidase (GSH-Px) was measured accord-
ing to the method described by Flohe and Gunzler [29].CAT was determined following the method described byAebi [30]. SOD was assessed according to the methodpublished by Sun et al. [31].
Serological parameters measuring the function ofpancreas
The function of the pancreas was assessed by the measure-ment of serological concentration of glucose, insulin, lipase
and amylase. The concentration of glucose and amylasewas determined using an autoanalyzer Cobas Integra 400(Roche� Diagnostics, Indianapolis, IN, USA). The pan-creatic lipase was quantified using a commercial colorimet-
ric enzymatic test (LIPASE EE500; Linear Chemicals S.L.,BBI Diagnostics, West Bridgewater, MA, USA). Theinsulin was measured by radioimmunoassay using a com-
mercial assay (INSULIN-CT; CIS Bio International, OrisGroup, Gif/Yvette, France).
Measurement of apoptosis in pancreas
The evaluation of DNA fragmentation and caspase-3-
associated activity was used as index of apoptosis inpancreas [32, 33]. DNA fragmentation was assessed inpancreas (20 mg) homogenized (Ultra-turrax T25; Jankeand Kunkel IKA Laboratory, Stafen, Germany) in lysis
solution [1% SDS, 10 mm Tris-HCl, 50 mm ethylenediam-inetetraacetic acid (EDTA)], pH 7,4. Samples were incuba-ted with RNAse (1 mg/mL) (Sigma) for 2 hr at 37�C and
proteinase K (1 mg/mL) (Sigma) for 45 min at 48�C. DNAwas obtained by phenol:choloform:isoamyl alcohol 25:24:1(Sigma) extraction and precipitated with isopropanol (v/v)
and 0.5 m NaCl for 12 hr at )20�C. DNA was recovered bycentrifugation at 15,000 g for 20 min, and the precipitated
Munoz-Casares et al.
196
was washed with 70% ethanol, dried, and re-suspended inTris-EDTA buffer (10 mm Tris, 50 mm EDTA), pH 7.4.Samples (250 lg DNA) were applied and analyzed on 2%
agarose gel with ethidium bromide (0.5 lg/mL). In order tocarry out a statistical analysis of the results, it wasdetermined the absorbance of each band of the ladderobserved in agarose gel.
The evaluation of caspase-3-associated activity wasassessed in pancreas (20 mg) homogenized (Ultra-turraxT25) in lyses solution (50 mm Tris-HCl pH 7.5, 2 mm
EDTA, 100 mm NaCl, 1% nonidet NP-40, 1 mm phenyl-methylsulfonyl fluoride, 20 lg/mL aprotinin, 20 lg/mLleupeptin and 20 lg/mL pepstatin A) at 4�C for 10 min,
transferred to Eppendorf tubes and centrifuged at 20,800 gat 4�C for 5 min. The caspase-3-like activity in the cellextract (25 lg) was measured by colorimetric assay usingthe peptide-based substrate ac-N-acetyl-Asp-Glu-Val-Asp-
p-nitoanilide (AcDEVD-pNA) (Bachem AG, Bubendorf,Switzerland). The increase in absorbance of enzymaticallyreleased pNA was measured at 405 nm for 10 min in a
DU� 640 Spectrophotometer (Beckman Coulter, Inc.,Fullerton, CA, USA).
Histological examination
The injury of the pancreas was evaluated by histological
examination of tissue sections (5 lm) fixed with 4%paraformaldehyde solution pH 7.0 and embedded inparaffin. After removing paraffin with xylol, the sectionswere stained with hematoxylin-eosin or periodide-acid
Schiff [34]. The histological observation was carried outusing an optical microscope (Nikon�. Biophot, Tokyo,Japan) by different independent anatomopathologist. The
expert graded the severity of the injury based on theprevious experimental studies [10, 11, 35] (Table 1).
Statistical analysis
All results were expressed as mean ± standard error. Ifdata followed a normal distribution, the differences
between groups were assessed by the one-way analysis ofvariance (ANOVA) using the multiple comparison Tukeytest for independent samples. In order to compare paired
samples using the time of killing after IR as a factor, datawere submitted to multiple mean ANOVA using DMS testas post hoc analysis. When normal distribution was not
observed, data was submitted to post hoc Kruskal–Wallisand Mann–Whitney tests for independent samples, andpost hoc Friedman and Wilcoxon tests for paired samples.
For the measurement of the percentage of histologicalinjury between samples a chi-squared test (v2) was used foranalysis in a data matrix structure. The v2 analysis with
Yates correction was used in the case of matrix 2 · 2. Whenthe expected frequency was lower than 5 Fisher test wasapplied.The statistical significance was set at P < 0.05 and
indicated using superscript symbols in the figures.
Results
Different parameters related to lipoperoxidation and anti-oxidants (GSH, SOD, CAT and GSH-Px) have been
assessed in pancreas from IR rats treated or not treatedwith melatonin (Fig. 1). IR increased significantly thegeneration of lipoperoxides in pancreas in comparison withthe SO group (P < 0.001). This exacerbation of tissue
oxidative injury was correlated with a depletion ofantioxidant status (GSH, SOD, CAT and GSH-Px) inpancreas. All groups treated with melatonin showed a
marked reduction of lipoperoxides and a recovery ofantioxidant values of the IR animals.Ischemia/reperfusion induced a significant reduction of
insulin concentration in serum at 24 and 48 hr after injury(P < 0.001) (Fig. 2A). Nevertheless, this effect was notaccompanied by any changes on glucose concentration
between SO and IR groups (144 ± 11.2 versus 178 ± 54.9at 24 hr and 210 ± 49.7 versus 189 ± 45.0 at 48 hr,respectively). The administration of melatonin restoredthe level of insulin in IR animals reaching the control values
at 48 hr in MEL-IR-MEL animals (Fig. 2A).The level of amylase and lipase in serum increased
rapidly in rats subjected to IR compared with SO group at
24 hr (P ¼ 0.032 and P < 0.001, respectively) and 48 hr(P ¼ 0.009 and P < 0.001, respectively) (Fig. 2B,C). Mela-tonin administration reduced significantly lipase in all IR
group at 24 and 48 hr (P < 0.001) (Fig. 2C). Nevertheless,melatonin was only able to diminish significantly theconcentration of amylase at 48 hr in IR rats treated withmelatonin (P < 0.01) (Fig. 2B).
The fragmentation of DNA and caspase-3 activity wereused as a markers of apoptosis in pancreas (Figs 3 and 4).A relevant increase on DNA fragmentation in pancreas was
only observed 24 hr after IR (Fig. 3A). This observationwas confirmed with the measurement of absorbance ofethidium bromide band in agarose gel (Fig. 3B). Caspase-3
activity also raised 24 hr after IR in pancreas homogenate(Fig. 4). Melatonin prevented the increase of DNA frag-mentation and caspase-3 activity in pancreas from
IR-subjected rats (Figs 3 and 4).
Table 1. Degree of histological injuryaccording to the presence of edema,inflammatory infiltrates necrosis andhemorrhage
Tissue injury EdemaInflammatoryinfiltrates Necrosis Hemorrhage
LEVEL 0No or mild pancreatitis No/Minimum No/Minimum No No
LEVEL 1Moderate pancreatitis Relevant Relevant No No
LEVEL 2Acute pancreatitis Intense Intense Yes Yes
Melatonin prevents injury to pancreas
197
The histological analysis showed that the acini were wellconserved, defined and without edema or inflammatoryinfiltrate in pancreas from SO rats (Fig. 5A–D). Weobserved that 24 hr IR induced acute edematous pancre-
atitis, marked interacinar edema, vascular congestion and
an interstitial inflammatory infiltrate (Fig. 5B). At 48 hr,the majority of pancreas (80%) showed an exacerbation ofacute pancreatitis with an important accumulation ofinflammatory infiltrates in the injured area that included
an extensive cell necrosis with disruption of the acini and
0
0
0
1
2
3
4
5
6
2468
10121416
0
0.05
0.1
0.15
0.2
0.25
0.3
24 hr 48 hr
24 hr 48 hr
24 hr 48 hr
24 hr 48 hr
24 hr
SO
IR
MEL-IR
MEL-IR-MEL
IR-MEL
48 hr
***
1020304050607080
µmol/mg
U/mg
U/mg
SOD
GSH-Px
µmol/mgLipoperoxidesA
C
E
D
B GSH
*** **
****
***
***
***
***
**
**
**
***
*
***
*****
****
** **U/mg
Catalase
***
***
**
****
***
00.020.040.060.080.1
0.120.140.160.18
****
*****
***
Fig. 1. Effect of melatonin on lipoperox-ides, reduced glutathione (GSH), super-oxide dismutase (SOD), catalase (CAT)and glutathione peroxidase (GSH-Px)levels in pancreas subjected to ischemia/reperfusion (IR). All groups were com-pared statistically with the IR group.*P < 0.05, **P < 0.01, ***P < 0.001.
0
24 hr 48 hr
24 hr 48 hr
***
0.51
1.52
2.53
3.5ng/mL
Insulin Amilase
Lipase
U/L
U/L
500045004000350030002500200015001000500
0
A B
C
***
****
***
***
***
***
**** ** **
6000
5000
4000
3000
2000
1000
0
SO
IR
MEL-IR
MEL-IR-MEL
IR-MEL
*** **
****
***
***
***
***
**
Fig. 2. Effect of melatonin on insulin,amylase and lipase serum concentrationafter the induction of ischemia/reper-fusion (IR) in pancreas. All groups werecompared statistically with the IR group.*P < 0.05, **P < 0.01, ***P < 0.001.
Munoz-Casares et al.
198
lobule structures, as well as the presence of variablehemorrhage (Fig. 5C).The comparative histological analysis showed that
although the administration of a single dose of melatoninbefore or after IR did not prevent the induction of acuteedematous pancreatitis at 24 hr IR, the antioxidant wasable to prevent any further evolution to grave acute
pancreatitis at 48 hr (Fig. 5D). In addition, a remarkablecytoprotective effect of melatonin was observed in MEL-IR-MEL animals. In this group, a normal histological or
minimum interacinar edema (60%) and acute edematouspancreatitis (40%) were observed at 24 hr after IR.Melatonin cytoprotection was even more pronounced at
48 hr after IR when 80% of pancreas showed normalhistology (Fig. 6).
Discussion
During the last decade, melatonin has been intensivelyinvestigated for its potent antioxidant properties, broad
absorption and low side effects. These properties suggestthat melatonin may be useful for treating all oxidativestress-related dysfunctions including IR syndrome [36,
37]. Numerous recent evidence suggests that the genera-tion of free radicals mediates the injury in differenttissues, such as pancreas, induced during IR syndrome
[38–40]. Nevertheless, in spite of the antioxidant proper-ties demonstrated by melatonin, the studies involving itsuse for the treatment of oxidative stress-induced damagein pancreas is limited [41–44]. In this sense, only the
study conducted by Jaworek et al. [45] has shown thatthe administration of melatonin reduces lipid peroxida-tion and pancreatic edema, and improves interleukin-10,
tumor necrosis factor-a and amylase concentration inserum during IR. We found no study that correlates theinduction of oxidative stress, lipid peroxidation, cell
death, histological disturbances and cell dysfunctioninduced by IR in pancreas. In addition, the study ofthe protective effects of melatonin against IR has aremarkable therapeutic interest for the treatment of
patients suffering from blood flow obstruction. Thepancreas is subjected to IR injury during tissue trans-plantation and other numerous pathological situations
characterized by a reduction in abdominal blood flowsuch as post-traumatic hemorrhage, septic syndromes,cardiopathies, vascular dysfunction, embolic-thrombosis
processes, and all surgical interventions in which regionalarterial bypass or vascular clamp are required.In the present study, IR induced an intense oxidative
stress characterized by an increase of lipid peroxides anddepletion of enzymatic (CAT, SOD and GSH-Px) and non-enzymatic (GSH) antioxidants in pancreas. The treatmentof melatonin exerted a powerful antioxidant effect with a
reduction of free radical-derived products,MDA + 4HNE, and recovery of antioxidant status inpancreas subjected to IR. Melatonin restored CAT and
GSH-Px activities in pancreas to levels similar to thosefound in the SO group. Although, the administration ofmelatonin before IR exerted the highest cytoprotective
effect against injured pancreas, the therapeutic administra-tion also exerted a remarkable positive effect on tissue
A
B
SO
IR
MEL-IR
MEL-IR-MEL
Arbitraryunits
Base pairs
1230
1033
653517
391
298234
Groups 1 2 3 4 5 6 7 8 9 10 11 12 13
1400
1200
1000
800
600
400
200
024 hr
***
48 hr
IR-MEL
*** *
**
**
Fig. 3. Effect of melatonin on DNA fragmentation in pancreasfrom animals subjected to ischemia/reperfusion (IR). (A) Repre-sentative image of DNA fragmentation in agarose gel. Groups are:(1) Control, (2) sham operated (SO) (24 hr), (3) sham operated plusmelatonin (SO-MEL) (24 hr) (4) SO (48 hr), (5) SO-MEL (48 hr),(6) ischemia/reperfusion (IR) (24 hr), (7) melatonin administrationbefore IR (MEL-IR) (24 hr), (8) melatonin administration after IR(IR-MEL) (24 hr), (9) MEL-IR-MEL (24 hr), (10) IR (48 hr), (11)MEL-IR (48 hr), (12) IR-MEL (48 hr), (13) MEL-IR-MEL(48 hr). In (B) statistical analysis of the absorbance of each band ofthe ladder corresponding to DNA fragmentation from all groupscompared with IR animals. *P < 0.05, **P < 0.01,***P < 0.001.
SO
IR
MEL-IR
MEL-IR-MEL
Abs/(h × mg protein)
4
3.5
3
2.5
2
1.5
1
0.5
024 hr 48 hr
**
IR-MEL
**
**
***
Fig. 4. Effect of melatonin on the caspase-3 activity in pancreasfrom animals subjected to ischemia/reperfusion (IR). All groupswere compared statistically with the IR group. *P < 0.05,**P < 0.01, ***P < 0.001.
Melatonin prevents injury to pancreas
199
oxidative stress and cell dysfunction in pancreas induced byIR.As observed by others [10], our study also showed that
IR syndrome in pancreas reduced insulin concentration in
blood. The administration of melatonin before or after IRimproved insulin concentration in serum. Double admin-
istration of melatonin fully recovered basal insulin con-centration 48 hr after IR. In our study, we could notobserve any correlation between insulin and glucoseconcentration in plasma. It is possible that the ischemia
for 1 hr was not sufficient to alter glucose concentration inserum.
A B
C
E
D
Fig. 5. (A) Histological analysis of pancreas from control rats. Pancreatic acini are well conserved, defined, without edema or inflammatoryinfiltrate. A normal islet is present. (B) Photomicrography of a pancreas subjected to ischemia/reperfusion injury for 24 hr. Acute edematouspancreatitis characterized by an inflammatory infiltrate and interacinar edema are apparent. The acini structure is well conserved withoutnecrosis or hemorrhage. (C) Histological appearance of a pancreas subjected to ischemia/reperfusion injury for 48 hr. Acute necroticpancreatitis with hemorrhage characterized by the presence of extensive inflammatory infiltrate with parenchymal necrosis, as well asnecrosis of adipocytes (D) in lobules and acini are apparent. (E) Photomicrography of a pancreas subjected to ischemia/reperfusion injury(48 hr) with administration of melatonin before and after ischemia. The section shows normal histology similar to that observed in controlanimals. All sections are stained with hematoxylin-eosin. Magnification 40·.
Munoz-Casares et al.
200
In concordance with others [7, 16], we have shown asignificant rise in amylase and lipase concentration in serumafter IR. Melatonin abolished the increase of both enzymesafter IR especially when the antioxidant was administered
before ischemia.Our study also elucidated the relationship between the
cytoprotective effect of melatonin against oxidative stress
and the recovery of glandular dysfunction and histologicaldamage induced by IR in the pancreas. Herein, weinvestigated the association between the alteration of
endocrine and exocrine pancreatic function and the pres-ence of cell death markers, such as apoptosis and necrosis,in pancreas after IR treated or untreated with melatonin.
Fujimoto et al. [16] detected apoptosis in pancreatic acini24 hr after IR injury. We have observed that IR increasedDNA fragmentation and caspase-3 activity in pancreas at24 hr. Melatonin prevents free radical induced apoptosis in
rat brain astrocytes [46]. The administration of melatoninbefore or after IR was able to prevent apoptosis inpancreas. We did not observe any signs of apoptosis at
48 hr after IR. Sandoval et al. [47] have suggested that theaccumulation of inflammatory infiltrate in the pancreas atthe last stage of IR may shift cell death from apoptosis to
necrosis. In agreement with these studies [16, 47], thereduction of apoptosis should be associated with anincrease of pancreatic cell necrosis. In this sense, a detailedhistological analysis of pancreas submitted to IR showed
the presence of acute pancreatitis. Several authors havenoted an increase of edema, accumulation of inflammatoryinfiltrate in lobules and acini, and the presence of cell
necrosis and hemorrhage in relation to the intensity of theinsult [16, 39, 48]. Our study has demonstrated the
presence of acute pancreatitis and the development ofedematous pancreatitis in all samples at 24 hr IR tonecrotic-hemorrhage pancreatitis in the 80% of organs at48 hr. This exacerbation of the tissue damage may explain
the lack of apoptotic markers at 48 hr after IR. Weconsider relevant the observation that melatonin, althoughthe presence of acute edematous pancreatitis in all samples
was maintained at 24 hr, prevented the induction ofnecrotic-hemorrhage pancreatitis at 48 hr after IR. Inaddition, the administration of melatonin before and after
IR reduced the number of samples evaluated at 24 hr withacute edematous pancreatitis to 40% while the remainingpancreas (60%) showed normal histology. At 48 hr, no
case of necrotic-hemorrhage pancreatitis was apparent,and 80% of the samples showed normal histology. Overall,this data clearly show that melatonin reduced all bio-chemical and histological markers of apoptosis and
necrosis induced by IR in pancreas.In conclusion, the administration of melatonin before or
after IR reduced oxidative stress, antioxidant depletion, cell
death and restored the pancreatic histological structure andfunction disrupted by the insult. Our study documents thatmelatonin administration may also have a positive impact
on surgical situations in which an ischemic process hasalready occurred and the restoration of blood flow is stillpossible.
Acknowledgments
This study was supported by the Programa de Promocion
de la Investigacion en Salud del Ministerio de Sanidad yConsumo (FIS 02/0155, RTIC C03/03, G03/156).
MEL-IR
IR-MEL MEL-IR-MEL
100% *
*
**
80
60
40
20
024 hr 48 hr
IR
100%
80
60
40
20
024 hr 48 hr
100%
80
60
40
20
0
24 hr 48 hr
100%
80
60
40
20
0
24 hr
No pancreatitis
Edematous pancreatitis
Necrotic pancreatitis
48 hrFig. 6. Comparative figures in relation tothe presence of edematous or necroticpancreatitis in rats subjected to ischemia/reperfusion (IR). All groups were com-pared statistically with the IR group.*P < 0.05, **P < 0.01.
Melatonin prevents injury to pancreas
201
References
1. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a
review. Microsurgery 1993; 14:165–175.
2. Carden DL, Granger DN. Pathophysiology of ischemia-
reperfusion injury. J Pathol 2000; 190:255–266.
3. Parks DA, Granger DN. Ischemia-induced vascular chan-
ges: role of xanthine oxidase and hydroxyl radicals. Am J
Physiol 1983; 245:G285–289.
4. Bulkley GB. Free radical-mediated reperfusion injury: a
selective review. Br J Cancer Suppl 1987; 8:66–73.
5. Oda T, Nakai I, Mituo M et al. Role of oxygen radicals and
synergistic effect of superoxide dismutase and catalase on isc-
hemia-reperfusion injury of the rat pancreas. Transplant Proc
1992; 24:797–798.
6. Tamura K, Manabe T, Kyogoku T et al. Effect of postis-
chemic reperfusion on the pancreas. Hepatogastroenterology
1993; 40:452–456.
7. Balen EM, Ferrer JV, Zazpe C et al. Assessment of oxida-
tive stress in a pancreatic warm ischemia-reperfusion model.
Transplant Proc 1998; 30:569–570.
8. Sanfey H, Bulkley GB, Cameron JL. The pathogenesis of
acute pancreatitis. The source and role of oxygen derived free
radicals in three different experimental models. Ann Surg 1985;
201:633–639.
9. Benz S, Schnabel R, Weber H et al. The nitric oxide
donor sodium nitroprusside is protective in ischemia/reper-
fusion injury on the pancreas. Transplantation 1998; 66:994–
999.
10. Yamamoto H, Sugitani A, Kitada H et al. Effect of
FR167653 on pancreatic ischemia-reperfusion injury in dogs.
Surgery 2001; 129:309–317.
11. Menger MD, Bonkhoff H, Vollmar B. Ischemia-reper-
fusion-induced pancreatitic microvascular injury. An intravital
fluorescence microscopic study in rats. Dig Dis Sci 1996;
41:823–830.
12. Benz S, Schnabel R, Morgenroth K et al. Ischemia/reper-
fusion injury of the pancreas: a new animal model. J Surg Res
1998; 75:109–115.
13. Schmidt J, Riedel D, Mithofer K. Pancreatic microcircu-
lation in edematous and necrotizing pancreatitis in the rat.
Gastroenterology 1994; 106:A321.
14. Knoefel WT, Kollias N, Warshaw AL et al. Pancreatic
microcirculatory changes in experimental pancreatitis of gra-
ded severity. Surgery 1994; 116:904–913.
15. Bassi D, Kollias N, Fernandez-Del Castillo C et al.
Impairment of pancreatic microcirculation correlates with the
severity of acute experimental pancreatitis. J Am Coll Surg
1994; 179:257–263.
16. Fujimoto K, Hosotani R, Wada M et al. Ischemia-reper-
fusion injury on the pancreas in rats: identification of acinar
cell apoptosis. J Surg Res 1997; 71:127–136
17. Cruz A, Padillo FJ, Tunez I et al. Melatonin protects
against renal oxidative stress after obstructive jaundice in rats.
Eur J Pharmacol 2001; 425:135–139.
18. Reiter R, Tang L, Garcia JJ et al. Pharmacological actions
of melatonin in oxygen radical pathophysiology. Life Sci 1997;
60:2255–2271.
19. Padillo FJ, Cruz A, Navarrete C et al. Melatonin pre-
vents oxidative stress and hepatocyte cell death induced by
experimental cholestasis. Free Radic Res 2004; 38:697–704.
20. Sewerynek E, Reiter RJ, Melchiorri D et al. Oxidative
damage in the liver induced by ischemia reperfusion: pro-
tection by melatonin. Hepatogastroenterology 1996; 43:898–
905.
21. Rodriguez-Reynoso S, Leal C, Portilla E et al. Effect of
exogenous melatonin on hepatic energetic status during isc-
hemia reperfusion: possible role of tumor necrosis factor-alpha
and nitric oxide. J Surg Res 2001; 100:141–149.
22. Sener G, Tosun O, Sehirli AO et al. Melatonin and N-ace-
tylcysteine have beneficial effects during hepatic ischemia and
reperfusion. Life Sci 2003; 72:2707–2718.
23. Pei Z, Pang SF, Cheung RT. Administration of melatonin
after onset of ischemia reduces the volume of cerebral infarc-
tion in a rat middle cerebral artery occlusion stroke model.
Stroke 2003; 34:770–775.
24. Kilic E, Kilic U, Reiter RJ et al. Prophylactic use of
melatonin protects against focal cerebral ischemia in mice: role
of endothelin converting enzyme-1. J Pineal Res 2004; 37:247–
251.
25. Lee YM, Chen HR, Hsiao G et al. Protective effects of
melatonin on myocardial ischemia/reperfusion injury in vivo.
J Pineal Res 2002; 33:72–80.
26. Cuzzocrea S, Costantino G, Mazzon E et al. Beneficial
effects of melatonin in a rat model of splanchnic artery
occlusion and reperfusion. J Pineal Res 2000; 28:52–63.
27. Ates B, Yilmaz I, Geckil H et al. Protective role of mela-
tonin given either before ischemia or prior to reperfusion on
intestinal ischemia-reperfusion damage. J Pineal Res 2004;
37:149–152.
28. Sener G, Sehirli AO, Keyer-Uysal M et al. The protective
effect of melatonin on renal ischemia-reperfusion injury in the
rat. J Pineal Res 2002; 32:120–126.
29. Flohe L, Gunzler WA. Assays of glutathione peroxidase.
Methods Enzymol 1984; 105:114–121.
30. AebiH.Catalase in vitro.MethodsEnzymol 1984; 105:121–126.
31. Sun Y, Oberley LW, Li Y. A simple method for clinical assay
of superoxide dismutase. Clin Chem 1988; 34:479–500.
32. Muntane J, Montero JL, Marchal T et al. Effect of PGE1
on TNF-alpha status and hepatic D-galactosamine-induced
apoptosis in rats. J Gastroenterol Hepatol 1998; 13:197–207.
33. Quintero A, Pedraza CA, Siendones E et al. PGE1 pro-
tection against apoptosis induced by D-galactosamine is not
relate to the modulation of intracellular free radical production
in primary culture of rat hepatocytes. Free Radic Res 2002;
37:345–355.
34. Rosai J. Gross techniques in surgical pathology. In: Acker-
man’s Surgical Pathology. Rosai J, ed. Mosby-Year Book,
St Louis Missouri, 1996; pp. 13–28.
35. Schmidt J, Rattner DW, Lewandrowski KB et al. A better
model of acute pancreatitis for evaluation therapy. Ann Surg
1992; 215:44–56.
36. Reiter RJ, Carneiro RC, Oh CS. Melatonin in relation to
cellular antioxidative defense mechanisms. Horm Metab Res
1997; 29:363–372.
37. Reiter RJ, Tan DX, Qi W et al. Pharmacology and physiol-
ogy of melatonin in the reduction of oxidative stress in vivo.
Biol Signals Recept 2000; 9:160–171.
38. Hoffmann TF, Leiderer R, Harris AG et al. Ischemia and
reperfusion in pancreas. Microsc Res Tesch 1997; 37:557–571.
39. Schulz HU, Niederan C, Klonowski-Stumpe H et al. Oxi-
dative stress in acute pancreatitis. Hepatogastroenterology
1999; 46:2736–2750.
40. Sweiry JH, Mann G. Role of oxidative stress in the patho-
genesis of acute pancreatitis. Scand J Gastroenterol 1996;
31:10–15.
Munoz-Casares et al.
202
41. Qi W, Tan DX, Reiter RJ et al. Melatonin reduces lipid
peroxidation and tissue edema in cerulein-induced acute pan-
creatitis in rats. Dig Dis Sci 1999; 44:2257–2262.
42. Ebelt H, Peschke D, Bromme HJ et al. Influence of mela-
tonin on free radical-induced changes in rat pancreatic beta-
cells in vitro. J Pineal Res 2000; 28:65–72.
43. Andersson AK, Sandler S. Melatonin protects against
streptozotocin, but not interleukin-1 beta induced damage of
rodent pancreatic beta-cells. J Pineal Res 2001; 30:157–165.
44. Vural H, Sabuncu T, Arslan SO et al. Melatonin inhibits
lipid peroxidation and stimulates the antioxidant status of
diabetic rats. J Pineal Res 2001; 31:193–198.
45. Jaworek J, Leja-Szpak A, Bonior J et al. Protective effect of
melatonin and its precursor L-tryptophane on acute pancrea-
titis induced by caerulein overstimulation on ischemia/reper-
fusion. J Pineal Res 2003; 34:40–52.
46. Jou MJ, Peng IT, Reiter RJ et al. Visualization of the anti-
oxidative effects of melatonin at the mitochondrial level during
oxidative stress-induced apoptosis of rat brain astrocytes.
J Pineal Res 2004; 37:55–70.
47. Sandoval D, Gukovskaya A, Reavey P et al. The role of
neutrophils and platelet-activating factor in mediating experi-
mental pancreatitis. Gastroenterology 1996; 111:1081–1091.
48. Obermaier R, Benz S, Kortmann B et al. Ischemia/reper-
fusion-induced pancreatitis in rats: a new model of complete
normothermic in situ ischemia of a pancreatic tail-segment.
Clin Exp Med 2001; 1:51–59.
Melatonin prevents injury to pancreas
203